A.R.T. Advisors, LLC - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 45 filers reported holding REPROS THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$55,000
-75.0%
34,315
-81.2%
0.00%
-70.0%
Q4 2015$220,000
+54.9%
182,501
+852.4%
0.01%
+100.0%
Q3 2015$142,00019,1620.01%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,132,367$9,727,0002.05%
RTW INVESTMENTS, LP 229,364$1,970,0000.89%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 361,300$3,104,0000.85%
DESTRIER CAPITAL MANAGEMENT LLC 329,030$2,826,0000.73%
SENZAR ASSET MANAGEMENT, LLC 244,006$2,096,0000.51%
GENERAL AMERICAN INVESTORS CO INC 508,375$4,367,0000.36%
CQS Cayman LP 700,000$6,013,0000.28%
Rotella Capital Management, Inc. 20,800$179,0000.15%
Baker Brothers Advisors 2,000,000$17,180,0000.14%
Gruss Capital Management LP 304,000$2,611,0000.11%
View complete list of REPROS THERAPEUTICS INC shareholders